How does GCP address participant safety in clinical trials?

The emphasis on informed consent and regular monitoring is a critical aspect of how Good Clinical Practice (GCP) addresses participant safety in clinical trials. Informed consent ensures that participants are fully aware of the risks and benefits of the trial before deciding to participate. It empowers them by providing necessary information about the study, allowing them to make an informed choice.

Regular monitoring is equally vital as it helps to identify any potential safety issues during the trial. This ongoing assessment enables researchers and ethics committees to respond quickly to any adverse events or unforeseen risks that may arise, thereby safeguarding participant welfare throughout the study.

By prioritizing these components, GCP ensures that participant safety is not only considered but is a fundamental aspect of clinical trial conduct. This systematic approach helps build trust between participants and researchers, reinforcing ethical standards in medical research.